Is It Too Late To Consider Onto Innovation (ONTO) After 191% One-Year Surge?
Onto Innovation ONTO | 0.00 |
- Wondering whether Onto Innovation at around US$274.76 is still reasonably priced after its strong run, or if you might be turning up late to the story.
- The stock has returned 6.2% over the past week, is down 9.9% over the past month, and sits on gains of 65.6% year to date and 191.3% over the past year, which can change how investors think about both upside and risk.
- Recent coverage around Onto Innovation has focused on its role within the semiconductor sector and how investors are reacting to its positioning and prospects. This context helps explain why the share price has moved sharply over different time frames as expectations are reassessed.
- Despite this strong share price history, Onto Innovation currently scores just 1 out of 6 on a set of undervaluation checks. The next step is a closer look at the standard valuation methods investors tend to use and, finally, a more complete way to think about what this stock may be worth.
Onto Innovation scores just 1/6 on our valuation checks. See what other red flags we found in the full valuation breakdown.
Approach 1: Onto Innovation Discounted Cash Flow (DCF) Analysis
A Discounted Cash Flow model projects a company’s future cash flows and then discounts them back to today’s value to estimate what the business might be worth right now.
For Onto Innovation, the DCF uses a 2 Stage Free Cash Flow to Equity approach based on cash flow projections in $. The latest twelve month free cash flow is about $234.7m. Analysts provide explicit forecasts for several years, then Simply Wall St extrapolates further, leading to a projected free cash flow of $833.5m in 2030. Between 2026 and 2035, the model uses a series of annual projections, each discounted back to today using the chosen rate.
Adding those discounted cash flows together produces an estimated intrinsic value of about $210.71 per share. Compared with the recent share price of around $274.76, the model implies Onto Innovation trades at a premium, with the stock assessed as around 30.4% overvalued using this method.
Result: OVERVALUED
Our Discounted Cash Flow (DCF) analysis suggests Onto Innovation may be overvalued by 30.4%. Discover 47 high quality undervalued stocks or create your own screener to find better value opportunities.
Approach 2: Onto Innovation Price vs Earnings
For profitable companies, the P/E ratio is a useful yardstick because it links what you pay for the stock to the earnings that support that price. In general, investors tend to accept higher P/E ratios when they expect stronger earnings growth or see lower risk, and look for lower P/E ratios when growth expectations are more modest or risks feel higher.
Onto Innovation currently trades on a P/E of 128.44x. That sits above both the Semiconductor industry average of 67.93x and the peer average of 79.33x, so on simple comparisons the stock screens as expensive. However, these straight comparisons do not factor in the company’s specific growth profile, profitability, size, or risk.
This is where Simply Wall St’s Fair Ratio comes in. The Fair Ratio of 67.64x represents an estimate of what Onto Innovation’s P/E might be if it were priced in line with its own earnings growth outlook, industry, profit margins, market cap and risk characteristics. Because it adjusts for these company specific features, it provides a more tailored reference point than broad peer or industry multiples. When compared with the current 128.44x P/E, the Fair Ratio suggests Onto Innovation trades at a premium to what this framework would indicate.
Result: OVERVALUED
P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 21 top founder-led companies.
Upgrade Your Decision Making: Choose your Onto Innovation Narrative
Earlier it was mentioned that there is an even better way to understand valuation. Meet Narratives, a feature on Simply Wall St’s Community page that lets you attach a clear story to your numbers by linking your view on Onto Innovation’s future revenue, earnings and margins to a specific forecast and Fair Value. You can then compare that Fair Value with today’s price to help you judge whether the stock looks appealing or stretched based on your own assumptions.
Each Narrative connects three pieces in one place: the company story you believe, the financial model that story implies, and the Fair Value that model produces. It updates when new information such as news or earnings is added so your view stays aligned with the latest data rather than a static spreadsheet.
For Onto Innovation, one investor might build a bullish Narrative using an implied Fair Value near US$380. Another might prefer a more moderate analyst style view around US$352, and a more cautious investor might lean toward a lower Fair Value close to US$220. By seeing these side by side you can quickly decide which story feels closest to your own expectations before making any buy or sell decision.
For Onto Innovation, however, we will make it really easy for you with previews of two leading Onto Innovation Narratives:
These are not predictions or advice, they are structured viewpoints from different investors that you can use as reference points when forming your own view.
Fair value: around US$380 per share.
Gap to current price: the stock sits roughly 27.7% below this fair value estimate based on a last close of US$274.76.
Revenue growth input used in this narrative: 19.93% a year.
- Positions Onto Innovation as a key semiconductor equipment provider focused on advanced AI packaging, HBM, and metrology tools at a critical bottleneck in the AI supply chain.
- Highlights TSMC qualification, a reported US$240m HBM related purchase agreement, and Semilab assets as support for higher earnings potential and operating leverage.
- Argues that applying peer style P/E multiples to projected earnings could justify a fair value around US$380, with the view that the market may not fully reflect Onto Innovation's role in AI packaging infrastructure.
Fair value: around US$220 per share.
Gap to current price: the stock sits roughly 24.9% above this fair value estimate based on a last close of US$274.76.
Revenue growth input used in this narrative: 18.65% a year.
- Flags higher operating costs from geopolitics, tariffs, regulation, and supply chain localization as potential headwinds for margins and long term profitability.
- Emphasizes competition in inspection and metrology, customer concentration, and the risk that export controls or semiconductor cyclicality could add volatility to revenue and earnings.
- Uses a fair value anchor of US$220 based on more cautious assumptions for earnings, margins, and future P/E, with the view that the stock may already reflect much of the HBM and advanced packaging story.
If you want to see how these stories are built in full, with the underlying forecasts and valuation logic laid out step by step, you can review the complete set of Narratives for Onto Innovation on Simply Wall St, compare them against your own assumptions, and decide where your view sits between the bullish and bearish cases.
To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Onto Innovation on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.
Do you think there's more to the story for Onto Innovation? Head over to our Community to see what others are saying!
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
